About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 605262, 7 pages
http://dx.doi.org/10.1155/2013/605262
Clinical Study

Interleukin 1-β, Interleukin-1 Receptor Antagonist, and Interleukin 18 in Children with Acute Spontaneous Urticaria

1Department of Pediatrics, Medical University of Silesia, Ulica 3-go Maja 13-15, 41-800 Zabrze, Poland
2Department of Microbiology and Immunology, Medical University of Silesia, Ulica Jordana 19, 41-808 Zabrze, Poland
3Chair and Clinical Department of Internal Diseases, Dermatology and Allergology, Medical University of Silesia, Ulica M. Curie-Skłodowskiej 10, 41-800 Zabrze, Poland

Received 11 April 2013; Revised 21 September 2013; Accepted 10 October 2013

Academic Editor: Ralph Mösges

Copyright © 2013 E. Machura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Leech, “Recurrent urticaria,” Paediatrics and Child Health, vol. 22, no. 7, pp. 281–286, 2012. View at Publisher · View at Google Scholar
  2. M. K. Church, K. Weller, P. Stock, and M. Maurer, “Chronic spontaneous urticaria in children: itching for insight,” Pediatric Allergy and Immunology, vol. 22, no. 1, pp. 1–8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Marrouche and C. Grattan, “Childhood urticaria,” Current Opinion in Allergy &s Clinical Immunology, vol. 12, no. 5, pp. 485–490, 2012. View at Publisher · View at Google Scholar
  4. E. Akinci, “The correlation between markers with the acute exacerbation and severity of the illness in patients with acute urticaria and angioedema,” Emergency Medicine, vol. 2, article 123, 2012. View at Publisher · View at Google Scholar
  5. M. Sakurai, M. Oba, K. Matsumoto, Y. Tokura, F. Furukawa, and M. Takigawa, “Acute infectious urticaria: clinical and laboratory analysis in nineteen patients,” Journal of Dermatology, vol. 27, no. 2, pp. 87–93, 2000. View at Scopus
  6. G. Ciprandi, M. de Amici, S. Legoratto, V. Giunta, M. Vignini, and G. Borroni, “Serum IL-9 levels in patients with spontaneous urticaria: a preliminary study,” Journal of Investigational Allergology & Clinical Immunology, vol. 22, no. 3, pp. 232–234, 2012.
  7. A. Kasperska-Zajac, J. Sztylc, E. Machura, and G. Jop, “Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients,” Clinical and Experimental Allergy, vol. 41, no. 10, pp. 1386–1391, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Fujii, K. Konishi, Y. Kanno, and N. Ohgou, “Acute urticaria with elevated circulating interleukin-6 is resistant to anti-histamine treatment,” Journal of Dermatology, vol. 28, no. 5, pp. 248–250, 2001. View at Scopus
  9. Z. Huilan, L. Runxiang, L. Bihua, and G. Qing, “Role of the subgroups of T, B, natural killer lymphocyte and serum levels of interleukin-15, interleukin-21 and immunoglobulin e in the pathogenesis of urticaria,” Journal of Dermatology, vol. 37, no. 5, pp. 441–447, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. C. dos Santos, M. H. Azor, V. Y. Nojima et al., “Increased circulating pro-inflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria,” International Immunopharmacology, vol. 8, no. 10, pp. 1433–1440, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Atwa, A. S. Emara, N. Youssef, and N. M. Bayoumy, “Serum concentration of IL-17, IL-23 and TNF-α among patients with chronic spontaneous urticaria: association with disease activity and autologous serum skin test,” Journal of the European Academy of Dermatology and Venereology, 2013. View at Publisher · View at Google Scholar
  12. T. Yoshimoto, H. Tsutsui, K. Tominaga et al., “IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 24, pp. 13962–13966, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. G.-Y. Kim, J.-W. Lee, H.-C. Ryu, J.-D. Wei, C.-M. Seong, and J.-H. Kim, “Proinflammatory cytokine IL-1β stimulates IL-8 synthesis in mast cells via a leukotriene B4 receptor 2-linked pathway, contributing to angiogenesis,” Journal of Immunology, vol. 184, no. 7, pp. 3946–3954, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. C. A. Dinarello, “Immunological and inflammatory functions of the interleukin-1 family,” Annual Review of Immunology, vol. 27, pp. 519–550, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Dinarello, “IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family,” Journal of Allergy and Clinical Immunology, vol. 103, no. 1, part 1, pp. 11–24, 1999. View at Scopus
  16. C. Sutton, C. Brereton, B. Keogh, K. H. G. Mills, and E. C. Lavelle, “A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis,” Journal of Experimental Medicine, vol. 203, no. 7, pp. 1685–1691, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. D. E. Smith, “The biological paths of IL-1 family members IL-18 and IL-33,” Journal of Leukocyte Biology, vol. 89, no. 3, pp. 383–392, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. J. S. Wild, A. Sigounas, N. Sur et al., “IFN-γ-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma,” Journal of Immunology, vol. 164, no. 5, pp. 2701–2710, 2000. View at Scopus
  19. D. Boraschi and C. A. Dinarello, “IL-18 in autoimmunity: review,” European Cytokine Network, vol. 17, no. 4, pp. 224–252, 2006. View at Scopus
  20. F. Martinon, A. Mayor, and J. Tschopp, “The inflammasomes: guardians of the body,” Annual Review of Immunology, vol. 27, pp. 229–265, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. F. L. van de Veerdonk, M. G. Netea, C. A. Dinarello, and L. A. B. Joosten, “Inflammasome activation and IL-1β and IL-18 processing during infection,” Trends in Immunology, vol. 32, no. 3, pp. 110–116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. D. R. Mason, P. L. Beck, and D. A. Muruve, “Nucleotide-binding oligomerization domain-like receptors and inflammasomes in the pathogenesis of non-microbial inflammation and diseases,” Journal of Innate Immunity, vol. 4, no. 1, pp. 16–30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Krause, M. Metz, M. Makris, T. Zuberbier, and M. Maurer, “The role of interleukin-1 in allergy-related disorders,” Current Opinion in Allergy & Clinical Immunology, vol. 12, no. 5, pp. 477–484, 2012. View at Publisher · View at Google Scholar
  24. A. Nambu and S. Nakae, “IL-1 and allergy,” Allergology International, vol. 59, no. 2, pp. 125–135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Tedeschi, M. Lorini, C. Suli, and R. Asero, “Serum interleukin-18 in patients with chronic ordinary urticaria: association with disease activity,” Clinical and Experimental Dermatology, vol. 32, no. 5, pp. 568–570, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Lenormand and D. Lipsker, “Efficiency of interleukin-1 blockade in refractory delayed pressure urticaria,” Annals of Internal Medicine, vol. 157, no. 8, pp. 599–600, 2012. View at Publisher · View at Google Scholar
  27. T. Kawayama, M. Okamoto, H. Imaoka, S. Kato, H. A. Young, and T. Hoshino, “. Interleukin-18 in pulmonary inflammatory diseases,” Journal of Interferon & Cytokine Research, vol. 32, no. 10, pp. 443–449, 2012. View at Publisher · View at Google Scholar
  28. W. P. Arend, “The balance between IL-1 and IL-1Ra in disease,” Cytokine and Growth Factor Reviews, vol. 13, no. 4-5, pp. 323–340, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Zuberbier, R. Asero, C. Bindslev-Jensen et al., “EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria,” Allergy, vol. 64, no. 10, pp. 1417–1426, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. J. G. Cannon, R. G. Tompkins, J. A. Gelfand et al., “Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever,” Journal of Infectious Diseases, vol. 161, no. 1, pp. 79–84, 1990. View at Scopus
  31. E. T. H. Yeh, “CRP as a mediator of disease,” Circulation, vol. 109, no. 21, supplement 1, pp. II11–II14, 2004. View at Scopus
  32. P. M. Jansen, M. A. Boermeester, E. Fischer et al., “Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin- 1α administration and during lethal bacteremia,” Blood, vol. 86, no. 3, pp. 1027–1034, 1995. View at Scopus
  33. A. Kasperska-Zajac and Z. Brzoza, “Increased d-dimer concentration in plasma of patients with severe acute urticaria,” British Journal of Dermatology, vol. 161, no. 6, pp. 1409–1410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Takahagi, S. Mihara, K. Iwamoto et al., “Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria,” Allergy, vol. 65, no. 5, pp. 649–656, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Takeda, Y. Sakurai, S. Takahagi et al., “Increase of coagulation potential in chronic spontaneous urticaria,” Allergy, vol. 66, no. 3, pp. 428–433, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. E. V. Granowitz, R. Porat, J. W. Mier et al., “Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans,” Blood, vol. 82, no. 10, pp. 2985–2990, 1993. View at Scopus
  37. L. M. Biasucci, G. Liuzzo, G. Fantuzzi et al., “Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events,” Circulation, vol. 99, no. 16, pp. 2079–2084, 1999. View at Scopus
  38. C. Jung, N. Gerdes, M. Fritzenwanger, and H. R. Figulla, “Circulating levels of interleukin-1 family cytokines in overweight adolescents,” Mediators of Inflammation, vol. 2010, Article ID 958403, 6 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Belani, L. Gensler, U. Bajpai et al., “Neutrophilic urticaria with systemic inflammation: a case series,” JAMA Dermatology, vol. 149, no. 4, pp. 453–458, 2013. View at Publisher · View at Google Scholar
  40. W. Wang, T. Tanaka, H. Okamura et al., “Interleukin-18 enhances the production of interleukin-8 by eosinophils,” European Journal of Immunology, vol. 31, no. 4, pp. 1010–1016, 2001.
  41. K. Kou, M. Aihara, T. Matsunaga et al., “Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis,” Archives of Dermatological Research, vol. 304, no. 4, pp. 305–312, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Puxeddu, P. Italiani, P. Giungato et al., “Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria,” Cytokine, vol. 61, no. 3, pp. 741–743, 2013. View at Publisher · View at Google Scholar
  43. S.-H. Kim, J. K. Son, E.-M. Yang, J.-E. Kim, and H.-S. Park, “A functional promoter polymorphism of the human IL18 gene is associated with aspirin-induced urticaria,” British Journal of Dermatology, vol. 165, no. 5, pp. 976–984, 2011. View at Publisher · View at Google Scholar · View at Scopus